Faced with declining demand for cardiovascular stents and pacemakers, Boston Scientific recently saw its second-quarter sales barely pick up from a year ago.
Now the Natick, Mass.-based company is trying to save as much as $275 million in annual expenses, by cutting between 1,200 and 1,400 positions worldwide.
The cuts will be made through a combination of attrition and layoffs, the company said last week.
Boston Scientific hasn't specified which divisions it's downsizing the most, but there is one place it won't be laying off droves of workers: China. It plans to expand its Chinese operations and create 1,000 new jobs there, in order to take advantage of the country's rapid growth.
These young job seekers graduated into the worst labor market since the Great Depression.
|Bruce Jenner interview: 'Yes, for all intents and purposes, I'm a woman.'|
|An Android robot is peeing on an Apple logo in Google Maps|
|Airlines saved $3.4 billion on lower fuel costs. But average fare fell only 66 cents|
|The American Dream is a myth, says Nobel-prize winner Joseph Stiglitz|
|Next for Bruce Jenner: Reality show for E!|